Aldeyra Therapeutics, Inc. Quarterly Return On Assets in % from Q3 2014 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Aldeyra Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2014 to Q2 2024.
  • Aldeyra Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -26.9 %, a 10.2% increase year-over-year.
  • Aldeyra Therapeutics, Inc. annual Return On Assets for 2023 was -24.2 %, a 22.4% increase from 2022.
  • Aldeyra Therapeutics, Inc. annual Return On Assets for 2022 was -31.2 %, a 19.4% decline from 2021.
  • Aldeyra Therapeutics, Inc. annual Return On Assets for 2021 was -26.1 %, a 46.7% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -26.9 +3.06 +10.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -20.3 +12.6 +38.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -24.2 +6.98 +22.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -28 +2.64 +8.61% Jul 1, 2023 Sep 30, 2023
Q2 2023 -30 -0.72 -2.46% Apr 1, 2023 Jun 30, 2023
Q1 2023 -32.9 -6.5 -24.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -31.2 -5.08 -19.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -30.7 -1.61 -5.54% Jul 1, 2022 Sep 30, 2022
Q2 2022 -29.3 +3 +9.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -26.4 +13.5 +33.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -26.1 +22.9 +46.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 -29 +23.8 +45% Jul 1, 2021 Sep 30, 2021
Q2 2021 -32.3 +36.3 +52.9% Apr 1, 2021 Jun 30, 2021
Q1 2021 -39.9 +36.1 +47.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -49 +28.2 +36.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -52.8 +16.9 +24.2% Jul 1, 2020 Sep 30, 2020
Q2 2020 -68.5 +0.01 +0.02% Apr 1, 2020 Jun 30, 2020
Q1 2020 -76 -6.03 -8.62% Jan 1, 2020 Mar 31, 2020
Q4 2019 -77.3 -5.33 -7.41% Oct 1, 2019 Dec 31, 2019
Q3 2019 -69.7 +15.5 +18.2% Jul 1, 2019 Sep 30, 2019
Q2 2019 -68.5 -2.28 -3.44% Apr 1, 2019 Jun 30, 2019
Q1 2019 -70 -6.12 -9.58% Jan 1, 2019 Mar 31, 2019
Q4 2018 -71.9 -12.9 -21.9% Oct 1, 2018 Dec 31, 2018
Q3 2018 -85.2 -24.6 -40.7% Jul 1, 2018 Sep 30, 2018
Q2 2018 -66.2 +4.34 +6.15% Apr 1, 2018 Jun 30, 2018
Q1 2018 -63.9 -0.48 -0.76% Jan 1, 2018 Mar 31, 2018
Q4 2017 -59 +8.55 +12.7% Oct 1, 2017 Dec 31, 2017
Q3 2017 -60.5 +4.19 +6.47% Jul 1, 2017 Sep 30, 2017
Q2 2017 -70.6 -11.9 -20.3% Apr 1, 2017 Jun 30, 2017
Q1 2017 -63.4 -12.3 -24.1% Jan 1, 2017 Mar 31, 2017
Q4 2016 -67.6 -23.4 -52.8% Oct 1, 2016 Dec 31, 2016
Q3 2016 -64.7 -19.5 -43% Jul 1, 2016 Sep 30, 2016
Q2 2016 -58.7 -7.47 -14.6% Apr 1, 2016 Jun 30, 2016
Q1 2016 -51.1 +14.9 +22.5% Jan 1, 2016 Mar 31, 2016
Q4 2015 -44.2 +17.1 +27.9% Oct 1, 2015 Dec 31, 2015
Q3 2015 -45.3 -136 -150% Jul 1, 2015 Sep 30, 2015
Q2 2015 -51.2 Apr 1, 2015 Jun 30, 2015
Q1 2015 -65.9 Jan 1, 2015 Mar 31, 2015
Q4 2014 -61.3 Oct 1, 2014 Dec 31, 2014
Q3 2014 91 Jul 1, 2014 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.